Detection of circulating tumor DNA (ctDNA) in untreated patients (pts) with cancer: Implications for early cancer detection (ECD)

被引:0
|
作者
Nakamura, Y. [1 ]
Tin, T. [2 ]
Krinshpun, S. [3 ]
Mitchell, B. [4 ]
Bristow, S. L. [5 ]
Aleshin, A. [6 ]
Magbanua, M. J. M. [7 ]
Van't Veer, L. J. [8 ]
Chapman, J. [9 ]
Andersen, C. Lindbjerg [10 ]
Tan, D. S. W. [11 ]
Yoshino, T. [1 ]
机构
[1] Hosp East, Natl Canc Ctr, Dept Gastroenterol & Gastrointestinal Onco, Kashiwa, Chiba, Japan
[2] Natera, R&D, San Carlos, CA USA
[3] Natera, Med Affairs, San Carlos, CA USA
[4] Natera, Translat Med, San Carlos, CA USA
[5] Natera, Sci Affairs, San Carlos, CA USA
[6] Natera, Early Canc Detect, San Carlos, CA USA
[7] UCSF, Lab Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[8] UCSF, Appl Genom, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[9] UCSF, Gynecol Oncol, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[10] Aarhus Univ Hosp, Mol Med, Aarhus, Denmark
[11] NCCS Natl Canc Ctr Singapore, Med Oncol Dept, Singapore, Singapore
关键词
D O I
10.1016/j.annonc.2023.09.2313
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1224P
引用
收藏
页码:S717 / S717
页数:1
相关论文
共 50 条
  • [1] Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
    Heo, J.
    Kim, Y. N.
    Lee, J. Y.
    Lee, S. T.
    Shin, S.
    Lee, Y. J.
    Kim, S. W.
    Choi, J. R.
    Kim, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S746 - S746
  • [2] Circulating Tumor DNA for Early Cancer Detection
    Fiala, Clare
    Kulasingam, Vathany
    Diamandis, Eleftherios P.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2018, 3 (02): : 300 - 313
  • [3] Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)
    Dworniczak, Juliane
    Rossenbach, Christiana
    Reisch, Simone
    Hart, Christian
    Fuzesi, Laszlo
    Dockhorn-Dworniczak, Barbara
    Dworniczak, Bernd
    LABORATORY INVESTIGATION, 2015, 95 : 513A - 513A
  • [4] Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)
    Dworniczak, Juliane
    Rossenbach, Christiana
    Reisch, Simone
    Hart, Christian
    Fuzesi, Laszlo
    Dockhorn-Dworniczak, Barbara
    Dworniczak, Bernd
    MODERN PATHOLOGY, 2015, 28 : 513A - 513A
  • [5] Detection of progression or regression of breast cancer by circulating tumor DNA (ctDNA)
    Karki, Ujjwal
    Ghimire, Bipin
    Herrman, Emma
    Yadav, Siddhartha
    Chisti, Mohammad Muhsin
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Exploring Circulating Tumor DNA (CtDNA) and Its Role in Early Detection of Cancer: A Systematic Review
    Bittla, Parikshit
    Kaur, Simran
    Sojitra, Vani
    Zahra, Anam
    Hutchinson, Jhenelle
    Folawemi, Oluwa
    Khan, Safeera
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [7] Circulating tumor DNA (ctDNA): can it be used as a pan-cancer early detection test?
    Duffy, Michael J.
    Crown, John
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2024, 61 (04) : 241 - 253
  • [8] Circulating tumor DNA (ctDNA) from patients (pts) with advanced colorectal cancer (CRC) is enriched for EGFR extracellular domain (ECD) mutations
    Tejpar, S.
    Tukachinsky, H.
    Zhang, L.
    Schrock, A. B.
    Decker, B.
    Pavlick, D. C.
    Venstrom, J.
    Nimeiri, H.
    Oxnard, G.
    ANNALS OF ONCOLOGY, 2021, 32 : S561 - S561
  • [9] Circulating tumor DNA as an early cancer detection tool
    Campos-Carrillo, Andrea
    Weitzel, Jeffrey N.
    Sahoo, Prativa
    Rockne, Russell
    Mokhnatkin, Janet V.
    Murtaza, Muhammed
    Gray, Stacy W.
    Goetz, Laura
    Goel, Ajay
    Schork, Nicholas
    Slavin, Thomas P.
    PHARMACOLOGY & THERAPEUTICS, 2020, 207
  • [10] Meta-analysis of the prognostic value of circulating tumor DNA (ctDNA) in patients (pts) with early breast cancer (EBC)
    Saoudi Gonzalez, N.
    Papakonstantinou, A.
    Pimentel, I.
    Sunol, A.
    Bellet, M.
    Zamora, E.
    Ortiz, C.
    Saura Manich, C.
    Villacampa Javierre, G.
    Antunes De Melo e Oliveira, A. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S427 - S427